pubmed-article:20957442 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:20957442 | lifeskim:mentions | umls-concept:C0035820 | lld:lifeskim |
pubmed-article:20957442 | lifeskim:mentions | umls-concept:C0012655 | lld:lifeskim |
pubmed-article:20957442 | lifeskim:mentions | umls-concept:C0546837 | lld:lifeskim |
pubmed-article:20957442 | lifeskim:mentions | umls-concept:C0664336 | lld:lifeskim |
pubmed-article:20957442 | lifeskim:mentions | umls-concept:C0017337 | lld:lifeskim |
pubmed-article:20957442 | lifeskim:mentions | umls-concept:C0038952 | lld:lifeskim |
pubmed-article:20957442 | lifeskim:mentions | umls-concept:C0086860 | lld:lifeskim |
pubmed-article:20957442 | lifeskim:mentions | umls-concept:C1882417 | lld:lifeskim |
pubmed-article:20957442 | lifeskim:mentions | umls-concept:C0021201 | lld:lifeskim |
pubmed-article:20957442 | lifeskim:mentions | umls-concept:C1709269 | lld:lifeskim |
pubmed-article:20957442 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:20957442 | pubmed:dateCreated | 2011-2-24 | lld:pubmed |
pubmed-article:20957442 | pubmed:abstractText | Survivin is an upregulated inhibitor of apoptosis protein in esophageal cancer (EC), and a promoter region polymorphism (-31G>C) in the survivin gene has been reported as a modulator of gene expression. We aim to explore the role of survivin -31G>C polymorphism in susceptibility and survival of EC patients in northern Indian population. | lld:pubmed |
pubmed-article:20957442 | pubmed:language | eng | lld:pubmed |
pubmed-article:20957442 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20957442 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:20957442 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20957442 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:20957442 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:20957442 | pubmed:month | Mar | lld:pubmed |
pubmed-article:20957442 | pubmed:issn | 1534-4681 | lld:pubmed |
pubmed-article:20957442 | pubmed:author | pubmed-author:MittalBalrajB | lld:pubmed |
pubmed-article:20957442 | pubmed:author | pubmed-author:KumarShaleenS | lld:pubmed |
pubmed-article:20957442 | pubmed:author | pubmed-author:GhoshalUday... | lld:pubmed |
pubmed-article:20957442 | pubmed:author | pubmed-author:KhuranaRohini... | lld:pubmed |
pubmed-article:20957442 | pubmed:author | pubmed-author:UpadhyayRohit... | lld:pubmed |
pubmed-article:20957442 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:20957442 | pubmed:volume | 18 | lld:pubmed |
pubmed-article:20957442 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:20957442 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:20957442 | pubmed:pagination | 880-7 | lld:pubmed |
pubmed-article:20957442 | pubmed:meshHeading | pubmed-meshheading:20957442... | lld:pubmed |
pubmed-article:20957442 | pubmed:meshHeading | pubmed-meshheading:20957442... | lld:pubmed |
pubmed-article:20957442 | pubmed:meshHeading | pubmed-meshheading:20957442... | lld:pubmed |
pubmed-article:20957442 | pubmed:meshHeading | pubmed-meshheading:20957442... | lld:pubmed |
pubmed-article:20957442 | pubmed:meshHeading | pubmed-meshheading:20957442... | lld:pubmed |
pubmed-article:20957442 | pubmed:meshHeading | pubmed-meshheading:20957442... | lld:pubmed |
pubmed-article:20957442 | pubmed:meshHeading | pubmed-meshheading:20957442... | lld:pubmed |
pubmed-article:20957442 | pubmed:meshHeading | pubmed-meshheading:20957442... | lld:pubmed |
pubmed-article:20957442 | pubmed:meshHeading | pubmed-meshheading:20957442... | lld:pubmed |
pubmed-article:20957442 | pubmed:meshHeading | pubmed-meshheading:20957442... | lld:pubmed |
pubmed-article:20957442 | pubmed:meshHeading | pubmed-meshheading:20957442... | lld:pubmed |
pubmed-article:20957442 | pubmed:meshHeading | pubmed-meshheading:20957442... | lld:pubmed |
pubmed-article:20957442 | pubmed:meshHeading | pubmed-meshheading:20957442... | lld:pubmed |
pubmed-article:20957442 | pubmed:meshHeading | pubmed-meshheading:20957442... | lld:pubmed |
pubmed-article:20957442 | pubmed:meshHeading | pubmed-meshheading:20957442... | lld:pubmed |
pubmed-article:20957442 | pubmed:meshHeading | pubmed-meshheading:20957442... | lld:pubmed |
pubmed-article:20957442 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:20957442 | pubmed:articleTitle | Role of survivin gene promoter polymorphism (-31G>C) in susceptibility and survival of esophageal cancer in northern India. | lld:pubmed |
pubmed-article:20957442 | pubmed:affiliation | Department of Genetics, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India. | lld:pubmed |
pubmed-article:20957442 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:20957442 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:20957442 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:332 | entrezgene:pubmed | pubmed-article:20957442 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:20957442 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:20957442 | lld:entrezgene |